A review of TSHR- and IGF-1R-related pathogenesis and treatment of Graves’ orbitopathy
Graves’ orbitopathy (GO) is an organ-specific autoimmune disease, but its pathogenesis remains unclear. There are few review articles on GO research from the perspective of target cells and target antigens. A systematic search of PubMed was performed, focusing mainly on studies published after 2015...
Main Authors: | Xuejiao Cui, Futao Wang, Cong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1062045/full |
Similar Items
-
Factors associated with severity of orbitopathy in patients with Graves' disease
by: Tauseef Nabi, et al.
Published: (2020-01-01) -
Roles of four targets in the pathogenesis of graves' orbitopathy
by: Ziqiang Ren, et al.
Published: (2023-09-01) -
Not All Orbitopathy Is Graves’: Discussion of Cases and Review of Literature
by: Neeraja Boddu, et al.
Published: (2017-07-01) -
Disulfiram Exerts Antifibrotic and Anti-Inflammatory Therapeutic Effects on Perimysial Orbital Fibroblasts in Graves’ Orbitopathy
by: Xing Wang, et al.
Published: (2022-05-01) -
Mechanisms That Underly T Cell Immunity in Graves’ Orbitopathy
by: Sijie Fang, et al.
Published: (2021-04-01)